SCM
IDYA icon

Sterling Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Sterling Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.9K Sell
1,554
-1,267
-45% -$38.8K ﹤0.01% 1539
2026
Q1 		$94K Sell
2,821
-1,836
-39% -$61.6K ﹤0.01% 1414
2025
Q4 		$161K Sell
4,657
-904
-16% -$28.8K ﹤0.01% 1362
2025
Q3 		$151K Buy
5,561
+3,299
+146% +$79.8K ﹤0.01% 1406
2025
Q2 		$47.5K Buy
2,262
+2,172
+2,413% +$41.7K ﹤0.01% 1519
2025
Q1 		$1.47K Buy
90
+5
+6% +$107 ﹤0.01% 2689
2024
Q4 		$2.19K Hold
85
– – ﹤0.01% 2763
2024
Q3 		$2.69K Buy
+85
New +$3.22K ﹤0.01% 2044

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Sterling Capital Management's IDYA Position: Q2 2026 in Review

Sterling Capital Management reduced its IDEAYA Biosciences (IDYA) stake by 45% in Q2 2026, selling an estimated $38.8K and leaving 1,554 shares worth $57.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1539.

Sterling Capital Management first reported a position in IDYA in Q3 2024 and has held it in 8 quarters since. The position peaked at $161K in Q4 2025. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Sterling Capital Management held 1,554 shares of IDEAYA Biosciences worth $57.9K as of Q2 2026.
  • Sterling Capital Management sold 1,267 IDEAYA Biosciences shares in Q2 2026, an estimated $38.8K.
  • IDEAYA Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1539 holding.
  • Sterling Capital Management first reported a position in IDEAYA Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's IDEAYA Biosciences position peaked at $161K in Q4 2025.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.